EA201990464A1 - MEDICINAL FORM OF EPHEDRINE AND ITS DERIVATIVES WITH PROTECTION AGAINST UNAUTHORIZED USE - Google Patents

MEDICINAL FORM OF EPHEDRINE AND ITS DERIVATIVES WITH PROTECTION AGAINST UNAUTHORIZED USE

Info

Publication number
EA201990464A1
EA201990464A1 EA201990464A EA201990464A EA201990464A1 EA 201990464 A1 EA201990464 A1 EA 201990464A1 EA 201990464 A EA201990464 A EA 201990464A EA 201990464 A EA201990464 A EA 201990464A EA 201990464 A1 EA201990464 A1 EA 201990464A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ephedrine
derivatives
protection against
unauthorized use
against unauthorized
Prior art date
Application number
EA201990464A
Other languages
Russian (ru)
Inventor
Кармен Штомберг
Клаус Венинг
Зебастиан Швир
Original Assignee
Грюненталь Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Грюненталь Гмбх filed Critical Грюненталь Гмбх
Priority claimed from PCT/EP2017/070396 external-priority patent/WO2018029327A1/en
Publication of EA201990464A1 publication Critical patent/EA201990464A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Данное изобретение относится к фармацевтической лекарственной форме, имеющей прочность при разрушении по меньшей мере 300 Н и содержащей эфедриновый компонент, выбранный из группы, состоящей из эфедрина, псевдоэфедрина и их физиологически приемлемых солей, при этом массовое содержание эфедринового компонента составляет от 0,1 до 60 мас.% относительно общей массы фармацевтической лекарственной формы.This invention relates to a pharmaceutical dosage form having a fracture toughness of at least 300 N and containing an ephedrine component selected from the group consisting of ephedrine, pseudoephedrine and their physiologically acceptable salts, wherein the mass content of the ephedrine component is from 0.1 to 60 wt.% relative to the total weight of the pharmaceutical dosage form.

EA201990464A 2017-05-30 2017-08-11 MEDICINAL FORM OF EPHEDRINE AND ITS DERIVATIVES WITH PROTECTION AGAINST UNAUTHORIZED USE EA201990464A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17173383 2017-05-30
PCT/EP2017/070396 WO2018029327A1 (en) 2016-08-12 2017-08-11 Tamper resistant formulation of ephedrine and its derivatives

Publications (1)

Publication Number Publication Date
EA201990464A1 true EA201990464A1 (en) 2019-08-30

Family

ID=58873655

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201990464A EA201990464A1 (en) 2017-05-30 2017-08-11 MEDICINAL FORM OF EPHEDRINE AND ITS DERIVATIVES WITH PROTECTION AGAINST UNAUTHORIZED USE

Country Status (1)

Country Link
EA (1) EA201990464A1 (en)

Similar Documents

Publication Publication Date Title
CY1122792T1 (en) MONO-OR DISUBTITUTED INDOLE DERIVATIVES AS DANGE VIRUS REPLICATION INHIBITORS
CL2019003309A1 (en) Substituted indoline derivatives as dengue virus replication inhibitors.
CL2019002745A1 (en) Substituted indoline derivatives as dengue virus replication inhibitors.
BR112017025108A2 (en) pyy selective compounds and uses thereof
CL2019002744A1 (en) Substituted indoline derivatives as dengue virus replication inhibitors.
CO2021006482A2 (en) Cyclic ureas
CL2019003294A1 (en) Substituted indoline derivatives as dengue virus replication inhibitors.
NZ764304A (en) Novel bradykinin b2 receptor antagonists
EA201992116A1 (en) PHARMACEUTICAL COMPOSITIONS OF FLOROGLUCINOL AND TRIMETHYLFLOROGLUCINOL
CY1124773T1 (en) TOPICAL PHARMACEUTICAL COMPOSITION CONTAINING AT LEAST AMITRIPTYLINE FOR THE THERAPEUTIC TREATMENT OF PERIPHERAL NEUROPATHIC ALGAE
MX2020012978A (en) Pharmaceutically acceptable salts of sepiapterin.
EA201890532A1 (en) NEW ANNELED BENZAMIDES
EA201992543A1 (en) Pyrolopyrimidine derivatives useful as influenza virus replication inhibitors
EA202192322A1 (en) PHARMACEUTICAL COMPOSITIONS
MX2019007213A (en) Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine.
EA202190398A1 (en) CONDENSED RING DERIVATIVE USED AS FGFR4 INHIBITOR
AR114418A1 (en) CYCLIC COMPOUND OF METHYLACTAM AND ITS PHARMACEUTICAL USE
BR112018073419A2 (en) combination, use of combination, method for treatment, compound, method for treatment of alzheimer's disease and pharmaceutical composition
NZ757526A (en) Naphthoquinones, their derivatives and uses thereof in methods for the treatment of mitochondrial dysfunction
BR112018073556A2 (en) medicament and pharmaceutical composition for the prevention or treatment of trigeminal neuralgia, method for preventing or treating trigeminal neuralgia in an individual, and use of a carbamate compound.
BR112017024126B8 (en) PHARMACEUTICAL COMPOSITIONS, MICRONIZED COMPOUND A AND/OR AT LEAST ONE MICRONIZED PHARMACEUTICALLY ACCEPTABLE SALT OF COMPOUND A AND USE THEREOF
EA201990464A1 (en) MEDICINAL FORM OF EPHEDRINE AND ITS DERIVATIVES WITH PROTECTION AGAINST UNAUTHORIZED USE
PH12020500120A1 (en) Pharmaceutical compositions
ECSP19024033A (en) THESOPHENSIN COMPOSITIONS
MX2019001738A (en) Tamper resistant formulation of ephedrine and its derivatives.